Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 08/04/20 | 8-K | Current report filing |
|
21 | |
| 08/03/20 | 8-K | Current report filing |
|
42 | |
| 07/21/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
17 | |
| 07/21/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 07/16/20 | 8-K | Current report filing |
|
5 | |
| 07/15/20 | 8-K | Current report filing |
|
5 | |
| 07/14/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
57 | |
| 07/14/20 | 8-K | Current report filing |
|
44 | |
| 07/13/20 | 8-K | Current report filing |
|
5 | |
| 07/10/20 | 8-K | Current report filing |
|
5 |
